Olfactomedin 4 deletion induces colon adenocarcinoma in Apc Min/+ mice

Olfm4 deletion enhances defense against Staphylococcus aureus in chronic granulomatous disease

(2013) Wenli Liu et al.   JOURNAL OF CLINICAL INVESTIGATION

Wnt/β-Catenin Signaling and Disease

(2012) Hans Clevers et al.   CELL

Intestinal Tumorigenesis Initiated by Dedifferentiation and Acquisition of Stem-Cell-like Properties

(2012) Sarah Schwitalla et al.   CELL

Progesterone and calcitriol attenuate inflammatory cytokines CXCL1 and CXCL2 in ovarian and endometrial cancer cells

(2012) Leyla Kavandi et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Olfactomedin 4 Inhibits Cathepsin C-Mediated Protease Activities, Thereby Modulating Neutrophil Killing of Staphylococcus aureus and Escherichia coli in Mice

(2012) W. Liu et al.   JOURNAL OF IMMUNOLOGY

Comprehensive molecular characterization of human colon and rectal cancer

(2012)   NATURE

Molecular Genetics of Colorectal Cancer

(2011) Eric R. Fearon   Annual Review of Pathology-Mechanisms of Disease

Notch signaling modulates proliferation and differentiation of intestinal crypt base columnar stem cells

(2011) K. L. VanDussen et al.   DEVELOPMENT

Constitutive IKK2 activation in intestinal epithelial cells induces intestinal tumors in mice

(2011) Katerina Vlantis et al.   JOURNAL OF CLINICAL INVESTIGATION

Olfactomedin-4 is a glycoprotein secreted into mucus in active IBD

(2011) Michael Gersemann et al.   Journal of Crohns & Colitis

A Quantitative Proteomic Approach of the Different Stages of Colorectal Cancer Establishes OLFM4 as a New Nonmetastatic Tumor Marker

(2011) Damien Besson et al.   MOLECULAR & CELLULAR PROTEOMICS

Olfactomedin 4 is a novel target gene of retinoic acids and 5-aza-2'-deoxycytidine involved in human myeloid leukemia cell growth, differentiation, and apoptosis

(2010) W. Liu et al.   BLOOD

Why not treat human cancer with interleukin-1 blockade?

(2010) Charles A. Dinarello   CANCER AND METASTASIS REVIEWS

The NLRP3 Inflammasome Protects against Loss of Epithelial Integrity and Mortality during Experimental Colitis

(2010) Md. Hasan Zaki et al.   IMMUNITY

Olfactomedin 4 down-regulates innate immunity against Helicobacter pylori infection

(2010) W. Liu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer

(2009) Sergei Grivennikov et al.   CANCER CELL

OLFM4 Is a Robust Marker for Stem Cells in Human Intestine and Marks a Subset of Colorectal Cancer Cells

(2009) Laurens G. van der Flier et al.   GASTROENTEROLOGY

Myocilin Is a Modulator of Wnt Signaling

(2009) H.-S. Kwon et al.   MOLECULAR AND CELLULAR BIOLOGY

The regulation ofOLFM4expression in myeloid precursor cells relies on NF-κB transcription factor

(2008) Kyung L. Chin et al.   BRITISH JOURNAL OF HAEMATOLOGY

Reduced hGC-1 Protein Expression Is Associated with Malignant Progression of Colon Carcinoma

(2008) W. Liu et al.   CLINICAL CANCER RESEARCH

Activated macrophages promote Wnt signalling through tumour necrosis factor-α in gastric tumour cells

(2008) Keisuke Oguma et al.   EMBO JOURNAL

Beyond Wnt inhibition: new functions of secreted Frizzled-related proteins in development and disease

(2008) P. Bovolenta et al.   JOURNAL OF CELL SCIENCE

Zebrafish Olfactomedin 1 Regulates Retinal Axon Elongation In Vivo and Is a Modulator of Wnt Signaling Pathway

(2008) N. Nakaya et al.   JOURNAL OF NEUROSCIENCE

Cancer-related inflammation

(2008) Alberto Mantovani et al.   NATURE